Table 3 Matched regression results of MIP vs. Non-MIP individuals, HUES 2007/2010
OR/B | Robust SE | p-value | Pseudo R2 | Log likelihood | Prob > chi2 | |
|---|---|---|---|---|---|---|
Patients reporting chronic illness (N = 3251) | ||||||
Outpatient service utilization | OR = 1.08 | 0.14 | 0.557 | 0.0002 | -1345.5572 | 0.5574 |
Self-treatment | OR = 0.77 | 0.15 | 0.172 | 0.0017 | -750.4796 | 0.1721 |
Total OOP provider fees (Gel) | B = - 16.31 | 12.63 | 0.197 | _ | _ | _ |
Total OOP drug expenditure (Gel) | B = - 9.61 | 6.29 | 0.127 | _ | _ | _ |
Patients reporting acute illness (N = 632) | ||||||
Outpatient service utilization | OR = 1.47 | 0.33 | 0.005 | 0.0053 | -419.38164 | 0.0849 |
Self-treatment | OR = 0.91 | 0.25 | 0.741 | 0.0003 | -348.22169 | 0.7414 |
Total OOP provider fees (Gel) | B = - 20.16 | 6.68 | 0.003 | _ | _ | _ |
Total OOP drug expenditure (Gel) | B = - 15.14 | 6.08 | 0.013 | _ | _ | _ |
Patients reporting chronic illness with acute complication (N = 712) | ||||||
Outpatient service utilization | OR = 1.28 | 0.23 | 0.178 | 0.0025 | -511.40943 | 0.1779 |
Self-treatment | OR = 0.65 | 0.12 | 0.018 | 0.0077 | -486.00092 | 0.0178 |
Total OOP provider fees (Gel) | B = - 20.02 | 11.08 | 0.071 | _ | _ | _ |
Total OOP drug expenditures | B = - 12.02 | 8.47 | 0.155 | _ | _ | _ |